• Home
  • Randomize
  • Aim and mission
  • News
  • Newsletters
  • Contact
  • Organization (investigators, collaborators and funders)
  • Data requests
    • Publication policy CONTRAST
    • DATA REQUEST FORM (internal parties)
    • DATA REQUEST FORM (external parties)
  • Work packages info
    • WP1: Improving microvascular reperfusion
    • WP2: MR ASAP
    • WP3A: MR CLEAN LATE
    • WP3B: MR CLEAN MED
    • WP3C: MR CLEAN NO-IV
    • WP4: Dutch ICH pilot
    • WP5: Biobank
    • WP6: Clinical data management
    • WP7: Imaging data management
    • WP8: Logistics and epidemiology
    • WPYT: Young talent program
  • Investigators
    • Randomize for MR CLEAN NO-IV
    • Randomize for MR CLEAN-LATE
    • Randomize for MR CLEAN-MED
    • Include for Dutch ICH pilot
    • Access to Open Clinica
    • Access to XNAT
    • Newsletter
    • CONTRAST PLAZA
  • Documents
  • Ongoing Trials
  • Closed trials
  • Links


« Previous 1 2 3 4

IRB approval

Published | By

Oct 19, 2017 – We are happy to announce the METC (IRB) Approval for MR CLEAN LATE, MR CLEAN MED, MR CLEAN NO-IV and MR ASAP. This approval was granted in October 2017 and includes a permission to defer consent until 24 hours after inclusion.

Posted in News
« Previous 1 2 3 4